Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

Panelists discuss how Julia prepares patients for treatment with amivantamab, including educating them on potential side effects and incorporating proactive strategies into treatment management to optimize patient care and minimize adverse effects.

EP: 1.Overview of EGFR-Mutant Advanced NSCLC

EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians

EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC

EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey

EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC

Now Viewing

EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

Video content above is prompted by the following:

• How do you prepare patients for treatment with amivantamab?
• What side effects do you educate your patients on?
• What proactive strategies do you incorporate into treatment management?

Recent Videos